Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-03-20
1998-12-15
Scheiner, Toni R.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 2431, 4353201, 435 691, 4352523, C07H 2104, C12N 1563, C12N 121
Patent
active
058498990
ABSTRACT:
The present invention provides a human tumor suppressor (TUPRO-2) and polynucleotides which identify and encode TUPRO-2. The invention also provides expression vectors and host cells, agonists, antibodies, or antagonists. The invention provides methods for treating diseases associated with expression of TUPRO-2.
REFERENCES:
Burgess et al. J. Cell Biol. 11:2129-2138, 1990.
Lazar et al. Mol. Cell. Biol. 8:1247-1252, 1988.
Tao et al. J. Immunol. 143(8):2595-2601, 1989.
Gillier et al. Human Antibodies & Hybridoma, 1(1):47-54, 1990.
Hillier, L. et al. GenBank, Accession Nos. M49458, R50367, 1995.
Knudson, A., "Antioncogenes and human cancer," Proc. Natl. Acad. Sci. USA, 90:10914-10921 (1993).
Antelman, D., et al., "Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110.sup.RB, the retinoblastoma tumor suppressor protein," Oncogene, 10:697-704 (1995).
Hamada, K., et al., "Adenovirus-mediated Transfer of a Wild-Type p53 Gene and Induction of Apoptosis in Cervical Cancer," Cancer Research, 56:3047-3054 (1996).
Todd, R., et al., "Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene," The FASEB Journal, 9:1362-1370 (1995) (GI 606837).
Gordon, H. et al., "Tumor Necrosis Factor Induces Genes Involved in Inflammation, Cellular and Tissue Repair, and Metabolism in Murine Fibroblasts," The Journal of Immunology, 148(12):4021-4027 (1992) (GI 202234).
Chang, F., et al., "Implications of the p53 Tumor-Suppressor Gene in Clinical Oncology," Journal of Clinical Oncology, 13(4):1009-1022 (1995).
Jacobson, D., et al., "Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer," Annals of Oncology, 6(3):S3-S8 (1995).
Vokes, E., et al., "Head and Neck Cancer," The New England Journal of Medicine, 328(3):184-194.
Silverman, S., et al., "Epidemiologic and demographic update in oral cancer: California and national data-1973 to 1985," JADA, 120:495-499 (1990).
Wong, D.T. (Direct Submission), GenBank Sequence Database (Accession U10249), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894, (GI 606837). 20 Mar. 1996.
Wong, D.T. (Direct Submission), GenBank Sequence Database (Accession U10249), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894, (GI 606836). 21 Mar. 1996.
Database EMBL, entry HS1146816, Accession No. AA227129, Feb. 27, 1997.
Database EMBL, entry HS458284, Accession No. N49458, Feb. 18, 1996.
Database EMBL, entry HS683280, Accession No. N48683, Feb. 18, 1996.
Hillman Jennifer L.
Shah Purvi
Billings Lucy J.
Incyte Pharmaceuticals Inc.
Johnson Nancy A.
Scheiner Toni R.
LandOfFree
Human tumor suppressor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human tumor suppressor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human tumor suppressor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1459357